Tharimmune Inc. (THAR) stock news · $187.4M cap
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
This THAR news page leads with what Tharimmune Inc. filed — not a scraped headline mill.
No cached 8-K sentence for THAR yet. We will not pad this page with generic market recap.
Latest reported THAR revenue for 2026-06-30 was $1.5M. Net income was -$19.3M. THAR currently screens at market cap $187.4M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the THAR stock page; for the tape open the quote page.
THAR stock news FAQ
What are THAR's latest revenue and net income?
Latest cached Tharimmune Inc. (THAR) revenue for Jun 30, 2026 was $1.5M. Net income was -$19.3M. Statements: https://lician.com/financials/thar
What is THAR's market cap?
Tharimmune Inc. (THAR) market cap is $187.4M on the latest cached fundamentals snapshot.
What kind of company is THAR?
Tharimmune Inc. (THAR) is a biotechnology company listed on NASDAQ.
Where is THAR stock news listed?
Cached stock news for Tharimmune Inc. (THAR) is listed at https://lician.com/news/thar. Filings: https://lician.com/sec/thar
Not investment advice.